// App-Quantinova.ai

2499 : Sox2 enhances breast tumor angiogenesis by promoting the transition of cancer cell to CD31+ and LYVE-1+ cells

Researchers

Presenter

  • Rongrong Wang

Principal Investigators

  • Xuefei Li

  • Yingxi Xu

  • Tongchao Sun

  • Weijun Su

  • Chenhua Yu

  • Xiaoli Dong

  • Rong Xiang

  • Na Li

Medical Centers

  • Key Lab of Tumor Microenvironment and Neurovascular Regulation, School of Medicine, Nankai University, Tianjin, China

  • The International Collaborative Laboratory for Biological Medicine of the Ministry of Education,School of Medicine, Nankai University, Tianjin, China

  • The Project Collaborative Innovation Center for Biological, School of Medicine, Nankai University, Tianjin, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 31

  • Kinase Insert Domain Receptor

  • Vascular endothelial growth factor B

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved